ArticleThoracic cancer2024

Tertiary lymphoid structures combined with biomarkers of inflammation are associated with the efficacy of neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: A retrospective study.

Fuhao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.